Lupin FDA Monday, June 12, 2017 0.00 Neutral

FDA Approves OXYCODONE HYDROCHLORIDE — Lupin Pharmaceuticals,Inc.

Lupin Pharmaceuticals, Inc. received FDA approval for its Oxycodone Hydrochloride generic on June 12, 2017, securing a position in the competitive opioid market and positioning the company to expand its generic portfolio and drive pharmaceutical sales growth.

View original filing at SEC.gov →

AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day